On this "Face the Nation with Margaret Brennan" broadcast, House Speaker Emerita Nancy Pelosi and Senate Majority Leader John Thune join Margaret Brennan.
Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives. According ...